ADAG
Price
$1.84
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
81.46M
67 days until earnings call
VXRT
Price
$0.74
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
168.34M
32 days until earnings call
Ad is loading...

ADAG vs VXRT

Header iconADAG vs VXRT Comparison
Open Charts ADAG vs VXRTBanner chart's image
Adagene
Price$1.84
Change-$0.00 (-0.00%)
Volume$7.92K
Capitalization81.46M
Vaxart
Price$0.74
Change-$0.00 (-0.00%)
Volume$1.04M
Capitalization168.34M
ADAG vs VXRT Comparison Chart
Loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAG vs. VXRT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and VXRT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ADAG: $1.84 vs. VXRT: $0.74)
Brand notoriety: ADAG and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 14% vs. VXRT: 51%
Market capitalization -- ADAG: $81.46M vs. VXRT: $168.34M
ADAG [@Biotechnology] is valued at $81.46M. VXRT’s [@Biotechnology] market capitalization is $168.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileVXRT’s FA Score has 0 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • VXRT’s FA Score: 0 green, 5 red.
According to our system of comparison, VXRT is a better buy in the long-term than ADAG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 3 TA indicator(s) are bullish while VXRT’s TA Score has 4 bullish TA indicator(s).

  • ADAG’s TA Score: 3 bullish, 2 bearish.
  • VXRT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ADAG is a better buy in the short-term than VXRT.

Price Growth

ADAG (@Biotechnology) experienced а -4.91% price change this week, while VXRT (@Biotechnology) price change was -6.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ADAG is expected to report earnings on Mar 27, 2025.

VXRT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VXRT($168M) has a higher market cap than ADAG($81.5M). VXRT YTD gains are higher at: 11.766 vs. ADAG (-7.538). ADAG has higher annual earnings (EBITDA): -31.51M vs. VXRT (-60.22M). ADAG has more cash in the bank: 95.7M vs. VXRT (58.7M). VXRT has less debt than ADAG: VXRT (18.2M) vs ADAG (20.8M). VXRT has higher revenues than ADAG: VXRT (20.1M) vs ADAG (816K).
ADAGVXRTADAG / VXRT
Capitalization81.5M168M49%
EBITDA-31.51M-60.22M52%
Gain YTD-7.53811.766-64%
P/E RatioN/AN/A-
Revenue816K20.1M4%
Total Cash95.7M58.7M163%
Total Debt20.8M18.2M114%
FUNDAMENTALS RATINGS
VXRT: Fundamental Ratings
VXRT
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGVXRT
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
89%
Momentum
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
84%
MACD
ODDS (%)
Bullish Trend 12 days ago
72%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 25 days ago
78%
Bullish Trend 14 days ago
75%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSMVX397.732.01
+0.51%
Vanguard S&P Small-Cap 600 Val Idx Instl
MKECX10.790.04
+0.37%
BlackRock Emerging Markets Ex-China K
TMCJX49.900.14
+0.28%
Touchstone Mid Cap C
KGIIX12.970.03
+0.23%
Kopernik International I
GIDAX7.000.01
+0.14%
Goldman Sachs Intl Eq Div & Prem A

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and IBO have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and IBO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
N/A
IBO - ADAG
25%
Poorly correlated
-3.11%
VXRT - ADAG
23%
Poorly correlated
-0.20%
CYBN - ADAG
22%
Poorly correlated
+2.24%
IGC - ADAG
22%
Poorly correlated
N/A
BCDA - ADAG
22%
Poorly correlated
+2.78%
More

VXRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VXRT has been loosely correlated with MDGL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VXRT jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VXRT
1D Price
Change %
VXRT100%
-0.20%
MDGL - VXRT
62%
Loosely correlated
+7.64%
AXON - VXRT
50%
Loosely correlated
+1.37%
ARRY - VXRT
48%
Loosely correlated
-0.14%
VERA - VXRT
42%
Loosely correlated
+1.80%
AMRN - VXRT
42%
Loosely correlated
+0.72%
More